NovaGenix Insights

FDA Removes Tirzepatide (Mounjaro, Zepbound) from Drug Shortage List: What It Means for Patients Using Compounded Versions and Reasons Behind There Sudden Reversal Tirzepatide No Longer in Short Supply: Impact on Compounded Medications for Weight Loss Tirzepatide No Longer in Short Supply: Impact on Compounded Medications for Weight Loss As of October 2024, the FDA has officially removed tirzepatide   (the active ingredient in Mounjaro and Zepbound) from its drug shortage list. This change follows months of high demand for tirzepatide, which is used for both diabetes and weight-loss treatments. Due to the rising popularity of GLP-1 medications for weight loss , many patients experienced difficulties obtaining them. Eli Lilly, the manufacturer, increased production capacity, restoring full availability in pharmacies. Lilly's drugs   have recently taken the world of weight loss by storm, however, this has impacted providers and patients who relied on affordable, effective comp...

Ozempic, Wegovy, and Mounjaro: Weighing the Benefits and Risks of GLP-1 Agonists The conversation around GLP-1 agonists like Ozempic, Wegovy, Mounjaro, Semaglutide , and Tirzepatide is becoming more prominent. With a wide range of opinions on their use and concerns over side effects, the discussion is often confusing. Recently, I listened to a podcast featuring Dr. Kimberly Anne Gudzune, MD, MPH on episode #405 of The Curbsiders Internal Medicine Podcas t , . The topic centered on GLP-1 agonists as tools for weight loss and managing obesity. The podcast offers key insights into the U.S. obesity epidemic, where 42% of adults are classified as obese by the Centers for Disease Control and Prevention (CDC) . The episode underlined the importance of personalized treatments rather than one-size-fits-all approaches for weight management. GLP-1 agonists, like Ozempic and Wegovy , work by mimicking natural peptides that regulate appetite and insulin response, leading to weight loss and ...

Patient-Centered TRT: Unveiling the Debate Between HCG and Gonadorelin Navigating HCG Supply: Challenges and Solutions for TRT Patients at NovaGenix health and wellness.   In the realm of Testosterone Replacement Therapy (TRT), the choice between Human Chorionic Gonadotropin (HCG) and Gonadorelin has become a pivotal consideration for both patients and clinicians alike. While HCG has long been a staple in TRT protocols, recent regulatory changes have prompted a shift towards Gonadorelin in some clinics. However, questions linger regarding efficacy, cost, availability, and patient preference between these two medications. This article discusses into the intricacies of this debate, offering insights into the comparative aspects of HCG and Gonadorelin in TRT and shedding light on the factors influencing the decision-making process for both providers and patients. Well answer common questions like, “Which medication is better?” “ Does Gonadorelin work? ” “ Can I still get hCG?” ...

Seeking hCG: An Overview and How to Obtain a Prescription Can I Still Get hCG?  Where can I find it online? Human chorionic gonadotropin ( hCG ) is a hormone with FDA approval for specific medical uses in both women and men. In pregnancy, hCG, produced by the placenta, plays roles in thickening the uterine lining and halting the menstrual cycle, earning it the moniker "pregnancy hormone." Detectable in urine or blood around 10 to 11 days post-conception, hCG levels peak by the end of the first trimester, ranging between 25,700 to 288,000 mIU/mL. The hormone's elevation stimulates estrogen and progesterone production, essential for pregnancy support. Available in various forms—such as injections and oral tablets—hCG's FDA-approved products come solely in injectable form, requiring a licensed medical professional's prescription. Despite the popular hCG diet, there are no FDA approved hCG products for weight loss , even though the hCG diet has been famous...